Table 4.
Parameter | Controls (n = 45) | CFS (n = 39) | GWI (n = 50) |
---|---|---|---|
MCGILL SCORE | |||
Sensory domain | 5.2 [3.2–7.3] | 13.9 [11.6–16.1]* | 16.2 [11.8–20.6]* |
Affective domain | 1.0 [0.47–1.5] | 4.1 [3.0–4.9]* | 6.1 [5.2–7.0]* |
Total score | 6.2 [3.7–8.7] | 17.8 [15.0–20.6]* | 23.8 [21.2–26.4]* |
MOS SF-36 | |||
Phys. Functioning | 77.4 [62.9–91.8] | 40.0 [33.2–46.8]* | 43.9 [35.6–52.1]* |
Role physical | 70.6 [51.2–89.9] | 7.1 [0.8–13.5]* | 12.9 [5.1–20.6]* |
Bodily pain | 68.1 [53.7–82.5] | 29.6 [23.9–35.3]* | 28.5 [22.3–34.7]* |
General health | 67.7 [54.1–81.3] | 34.7 [28.1–41.3]* | 27.6 [22.4–32.9]* |
Vitality | 58.2 [45.7–70.7] | 11.9 [7.9–15.7]* | 16.3 [12.3–20.3]* |
Social functioning | 75.7 [61.1–90.4] | 24.3 [17.9–30.7]* | 25.0 [18.9–31.9]* |
Role emotional | 84.3 [69.4–99.3] | 58.1 [43.1–73.1]* | 30.5 [18.1–42.9]* |
Mental health | 75.3 [69.1–81.5] | 64.7 [58.9–70.4]* | 50.1 [42.3–57.3]* |
GWI and CFS subjects self -reported significantly higher pain ratings on the McGill pain questionnaire. GWI and CFS subjects have significantly lower quality of life scores compared to controls for the eight SF-36 domains indicating impairment. (
vs. controls, P < 0.0001; ANOVA followed by Tukey's test; Mean [±95% CI]).